11 results match your criteria: "Sunnybrook and Women's Health Sciences Center[Affiliation]"

Pharmacodynamic and clinical implications of switching between P2Y12 receptor antagonists: considerations for practice.

Crit Pathw Cardiol

December 2014

From the *Terrence Donnelly Heart Centre, St. Michael's Hospital, University of Toronto, Toronto, ON, Canada; †St. Paul's Hospital, University of British Columbia, Vancouver, BC, Canada; ‡Sunnybrook and Women's Health Sciences Center, University of Toronto, Toronto, ON, Canada; §Vancouver General Hospital, University of British Columbia, Vancouver, BC, Canada; ¶Division of Cardiac Surgery, Keenan Research Centre for Biomedical Science, Li Ka Shing Knowledge Institute of St. Michael's Hospital, University of Toronto, Toronto, ON, Canada; ‖Rouge Valley Health System, Toronto, ON, Canada; and **Mazankowski Heart Institute, University of Alberta, Edmonton, Canada.

Dual antiplatelet therapy with aspirin and a P2Y12 receptor antagonist, either clopidogrel or the newer more potent agents prasugrel or ticagrelor, is standard therapy in patients receiving a coronary stent and those with a recent acute coronary syndrome. Switching antiplatelet drug regimen may be required in some patients for efficacy, safety, adherence, and cost considerations. However, there are potential concerns when switching from one agent to another that gaps in effective antiplatelet inhibition could lead to thrombotic events, and overlap of agents might cause excessive platelet inhibition thereby increasing the risk of bleeding.

View Article and Find Full Text PDF

X-Linked dominant chondrodysplasia punctata: prenatal diagnosis and autopsy findings.

Prenat Diagn

December 2006

Department of Medical Imaging, Women's College Campus, Sunnybrook and Women's Health Sciences Center, University of Toronto, Toronto, Ontario, Canada.

Objective: To report our experience of the prenatal diagnosis of X-linked dominant chondrodysplasia punctata (CDPX2) and highlight its variable phenotypic presentation.

Methods: We report the sonographic features of three female fetuses affected with CDPX2. The ultrasound, radiographic and pathological findings were compared.

View Article and Find Full Text PDF

The effectiveness of unannounced standardised patients in the clinical setting as a teaching intervention.

Med Educ

September 2004

Undergraduate Education Programme, Faculty of Medicine, Sunnybrook and Women's Health Sciences Center, University of Toronto, 2075 Bayview Avenue, Toronto, Ontario, Canada M4N 3M5.

Purpose: Teaching medical students to spontaneously identify biopsychosocial issues (e.g. family violence) remains a challenge.

View Article and Find Full Text PDF

Evaluating paramedic comfort with field pronouncement: development and validation of an outcome measure.

Acad Emerg Med

June 2003

Department of Emergency Services, Sunnybrook and Women's Health Sciences Center, Division of Emergency Medicine, Department of Medicine, University of Toronto, Ontario, Canada.

Objectives: Interventions designed to improve cardiac resuscitation and the quality of field pronouncement need to consider outcomes on paramedic providers. The authors developed and evaluated the reliability and validity of a survey instrument measuring paramedic comfort with field pronouncement.

Methods: A mail survey of 120 paramedics (EMT-Ps) was performed using the Modified Dillman survey methodology.

View Article and Find Full Text PDF

This study used environmental restrictions on foot movement to challenge the capacity of the central nervous system (CNS) to counter the lateral instability that arises after foot-lift during rapid triggered stepping reactions evoked by unpredictable postural perturbation. The objective was to determine the extent to which lateral stability could be regulated via modulation of the mediolateral (m-l) anticipatory postural adjustment (APA) that precedes foot-lift. A high frontal obstacle was used to double the required swing duration, and thereby increase the potential for the center of mass (COM) to fall laterally toward the unsupported side, during forward-step reactions.

View Article and Find Full Text PDF

Outcome of neck dissection for node-positive melanoma.

J Otolaryngol

June 2002

Department of Otolaryngology-Head and Neck Surgery, Sunnybrook and Women's Health Sciences Center, Toronto, Ontario.

Objective: To determine the rates of regional recurrence for node-positive melanoma after neck dissection alone.

Design: Retrospective review from a single tertiary care institution.

Methods: Data were obtained for all patients receiving neck dissection from 1990 to 1997 at Sunnybrook and Women's Health Sciences Center.

View Article and Find Full Text PDF

Tumor necrosis factor-alpha and transforming growth factor-beta reflect severity of liver damage in primary biliary cirrhosis.

J Gastroenterol Hepatol

February 2002

Division of Clinical Pharmacology, Sunnybrook and Women's Health Sciences Center, University of Toronto, Toronto, Ontario, Canada.

Background And Aims: The pathogenesis of primary biliary cirrhosis (PBC) is unknown. The role of cytokines such as tumor necrosis factor-alpha (TNF-alpha) and transforming growth factor-beta (TGF-beta), and the effect of ursodeoxycholic acid (UDCA) in modifying the cytokine environment in patients with PBC has remained largely unstudied. Our aims were to determine: (i) the relationship between serum levels of TNF-alpha and TGF-beta and the severity of PBC; and (ii) the effects of UDCA therapy on TNF-alpha and TGF-beta levels in patients with PBC.

View Article and Find Full Text PDF

Background: Alzheimer disease (AD) and vascular dementia are among the most frequently occurring causes of dementia in the world, and their accurate differentiation is important because different pharmaceutical strategies may modify the course of each disease.

Objective: To determine which of 10 neuropsychological test scores can accurately differentiate patients with probable AD from those with subcortical ischemic vascular dementia (SIVD) for use in evidence-based clinical practice.

Design: Patients with suspected dementia were referred to the study by family physicians, geriatricians, and neurologists.

View Article and Find Full Text PDF

A risk-benefit assessment of the newer oral antifungal agents used to treat onychomycosis.

Drug Saf

January 2000

Department of Medicine, Sunnybrook and Women's Health Sciences Center, University of Toronto Medical School, Canada.

The newer antifungal agents itraconazole, terbinafine and fluconazole have become available to treat onychomycosis over the last 10 years. During this time period these agents have superseded griseofulvin as the agent of choice for onychomycosis. Unlike griseofulvin, the new agents have a broad spectrum of action that includes dermatophytes, Candida species and nondermatophyte moulds.

View Article and Find Full Text PDF